Reports

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Cloning and Mutagenesis Market Size, Growth, Research: By Product: Cloning Kits, Mutagenesis Kit; By Technique: Topo PCR Cloning, Blunt End Cloning, Seamless Cloning, Site-Directed Mutagenesis, Others; Regional Analysis; Market Dynamics: SWOT Analysis; Competitive Landscape: Industry Events and Developments; 2023-2028

Global Cloning and Mutagenesis Market Outlook

The global cloning and mutagenesis market size is estimated to grow in the forecast period of 2023-2028 at a CAGR of 17.0%

 

North America to Hold a Significant Share in the Market Growth of Cloning and Mutagenesis

North America is holding a significant share in the cloning and mutagenesis market and is expected to register robust growth during the forecast period. This is on account of the huge investments in the research and development in the medical field, coupled with the well-developed healthcare industry in the region.

 

Rising investments in biotechnology companies and presence of market key players like Thermo Fisher Scientific Inc. and Codex DNA, Inc., among others is expected to drive the market growth. Moreover, the surging investment in the development of stem cell and cancer cell studies is further anticipated to bolster the market growth in North America.

 

Meanwhile, the Asia Pacific region is expected to witness considerable market growth due to the rapidly growing healthcare industry and increasing investments in biotechnology.

 

Market Segmentation

Cloning refers to the creation of duplicates of organisms either artificially, or naturally, with nearly identical DNA coding. Mutagenesis is a method of changing the genetic information of an organism encoded into the DNA. The adaptation and changes are performed in laboratory settings. Both techniques are used and under continued development to understand the relation of proteins.

 

By product, the cloning and mutagenesis market is divided into:

  • Cloning Kits
  • Mutagenesis Kit

 

Based on technique, the market is categorised into:

  • Topo PCR Cloning 
  • Blunt End Cloning 
  • Seamless Cloning 
  • Site-Directed Mutagenesis 
  • Others

 

On the basis of end use, the market is segmented into:

  • Biotechnology Companies 
  • Academic and Research Institute 
  • Others

 

The EMR report looks into the regional markets of cloning and mutagenesis like Latin America, North America, Europe, Asia Pacific, and the Middle East and Africa.

 

Increasing Demand for Reproductive Cloning to Propel the Market Growth of Cloning and Mutagenesis

The cloning and mutagenesis market is projected to witness substantial growth during the forecast period on account of the surging popularity of reproductive cloning. Going further, the various innovation and launch of product in the industry are proliferating the growth of the market. The rising penetration of personalised medications along with surging diseases is further expected to boost the market growth across the globe.

 

The growing cases of diseases such as cancer and HIV coupled with surging investment in the research of treatment for genetic diseases are propelling the market demand. The increasing efforts by governments such as providing funds for medical research coupled with the development of the biotechnology industry are encouraging the potential growth of the industry.

 

Key Players in the Global Market for Cloning and Mutagenesis

The report presents a detailed analysis of the following key players in the global cloning and mutagenesis market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

 

  • Thermo Fisher Scientific Inc. 
  • Takara Bio Inc. 
  • Codex DNA, Inc. 
  • Agilent Technologies, Inc. 
  • TransGen Biotech Co., Ltd. 
  • Others

 

The comprehensive report looks into the macro and micro aspects of the market. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2022
Historical Period 2018-2022
Forecast Period 2023-2028
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product
  • Technique
  • End Use
  • Region
Breakup by Product
  • Cloning Kits
  • Mutagenesis Kit
Breakup by Technique
  • Topo PCR Cloning
  • Blunt End Cloning
  • Seamless Cloning
  • Site-Directed Mutagenesis
  • Others
Breakup by End Use
  • Biotechnology Companies
  • Academic and Research Institute
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Thermo Fisher Scientific Inc.
  • Takara Bio Inc. 
  • Codex DNA, Inc.
  • Agilent Technologies, Inc.
  • TransGen Biotech Co., Ltd. 
  • Others

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Cloning and Mutagenesis Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Cloning and Mutagenesis Historical Market (2018-2022) 
    8.3    Global Cloning and Mutagenesis Market Forecast (2023-2028)
    8.4    Global Cloning and Mutagenesis Market by Product
        8.4.1    Cloning Kits
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2018-2022)
            8.4.1.3    Forecast Trend (2023-2028)
        8.4.2    Mutagenesis Kit
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2018-2022)
            8.4.2.3    Forecast Trend (2023-2028)
    8.5    Global Cloning and Mutagenesis Market by Technique
        8.5.1    Topo PCR Cloning
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2018-2022)
            8.5.1.3    Forecast Trend (2023-2028)
        8.5.2    Blunt End Cloning
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2018-2022)
            8.5.2.3    Forecast Trend (2023-2028)
        8.5.3    Seamless Cloning
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2018-2022)
            8.5.3.3    Forecast Trend (2023-2028)
        8.5.4    Site-Directed Mutagenesis
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2018-2022)
            8.5.4.3    Forecast Trend (2023-2028)
        8.5.5    Others
    8.6    Global Cloning and Mutagenesis Market by End Use
        8.6.1    Biotechnology Companies
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2018-2022)
            8.6.1.3    Forecast Trend (2023-2028)
        8.6.2    Academic and Research Institute
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2018-2022)
            8.6.2.3    Forecast Trend (2023-2028)
        8.6.3    Others
    8.7    Global Cloning and Mutagenesis Market by Region       
        8.7.1    North America
           8.7.1.1    Market Share
           8.7.1.2    Historical Trend (2018-2022) 
           8.7.1.3    Forecast Trend (2023-2028)
       8.7.2    Europe
           8.7.2.1    Market Share
           8.7.2.2    Historical Trend (2018-2022) 
           8.7.2.3    Forecast Trend (2023-2028)
       8.7.3    Asia Pacific
           8.7.3.1    Market Share
           8.7.3.2    Historical Trend (2018-2022) 
           8.7.3.3    Forecast Trend (2023-2028)
       8.7.4    Latin America
           8.7.4.1    Market Share
           8.7.4.2    Historical Trend (2018-2022) 
           8.7.4.3    Forecast Trend (2023-2028)
       8.7.5    Middle East and Africa
           8.7.5.1    Market Share
           8.7.5.2    Historical Trend (2018-2022) 
           8.7.5.3    Forecast Trend (2023-2028)
9    North America Cloning and Mutagenesis Market Analysis
    9.1    United States of America 
        9.1.1    Market Share
        9.1.2    Historical Trend (2018-2022) 
        9.1.3    Forecast Trend (2023-2028)
    9.2    Canada
        9.2.1    Market Share
        9.2.2    Historical Trend (2018-2022) 
        9.2.3    Forecast Trend (2023-2028)
10    Europe Cloning and Mutagenesis Market Analysis
    10.1    United Kingdom
        10.1.1    Market Share
        10.1.2    Historical Trend (2018-2022) 
        10.1.3    Forecast Trend (2023-2028)
    10.2    Germany
        10.2.1    Market Share
        10.2.2    Historical Trend (2018-2022) 
        10.2.3    Forecast Trend (2023-2028)
    10.3    France
        10.3.1    Market Share
        10.3.2    Historical Trend (2018-2022) 
        10.3.3    Forecast Trend (2023-2028)
    10.4    Italy
        10.4.1    Market Share
        10.4.2    Historical Trend (2018-2022) 
        10.4.3    Forecast Trend (2023-2028)
    10.5    Others
11    Asia Pacific Cloning and Mutagenesis Market Analysis
    11.1    China
        11.1.1    Market Share
        11.1.2    Historical Trend (2018-2022) 
        11.1.3    Forecast Trend (2023-2028)
    11.2    Japan
        11.2.1    Market Share
        11.2.2    Historical Trend (2018-2022) 
        11.2.3    Forecast Trend (2023-2028)
    11.3    India
        11.3.1    Market Share
        11.3.2    Historical Trend (2018-2022) 
        11.3.3    Forecast Trend (2023-2028)
    11.4    ASEAN
        11.4.1    Market Share
        11.4.2    Historical Trend (2018-2022) 
        11.4.3    Forecast Trend (2023-2028)
    11.5    Australia
        11.5.1    Market Share
        11.5.2    Historical Trend (2018-2022) 
        11.5.3    Forecast Trend (2023-2028)
    11.6    Others
12    Latin America Cloning and Mutagenesis Market Analysis
    12.1    Brazil
        12.1.1    Market Share
        12.1.2    Historical Trend (2018-2022) 
        12.1.3    Forecast Trend (2023-2028)
    12.2    Argentina
        12.2.1    Market Share
        12.2.2    Historical Trend (2018-2022) 
        12.2.3    Forecast Trend (2023-2028)
    12.3    Mexico
        12.3.1    Market Share
        12.3.2    Historical Trend (2018-2022) 
        12.3.3    Forecast Trend (2023-2028)
    12.4    Others
13    Middle East and Africa Cloning and Mutagenesis Market Analysis
    13.1    Saudi Arabia
        13.1.1    Market Share
        13.1.2    Historical Trend (2018-2022) 
        13.1.3    Forecast Trend (2023-2028)
    13.2    United Arab Emirates
        13.2.1    Market Share
        13.2.2    Historical Trend (2018-2022) 
        13.2.3    Forecast Trend (2023-2028)
    13.3    Nigeria
        13.3.1    Market Share
        13.3.2    Historical Trend (2018-2022) 
        13.3.3    Forecast Trend (2023-2028)
    13.4    South Africa
        13.4.1    Market Share
        13.4.2    Historical Trend (2018-2022) 
        13.4.3    Forecast Trend (2023-2028)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Competitive Landscape
    15.1    Market Structure
    15.2    Company Profiles
        15.2.1    Thermo Fisher Scientific Inc.
            15.2.1.1    Company Overview
            15.2.1.2    Product Portfolio
            15.2.1.3    Demographic Reach and Achievements
            15.2.1.4    Certifications
        15.2.2    Takara Bio Inc. 
            15.2.2.1    Company Overview
            15.2.2.2    Product Portfolio
            15.2.2.3    Demographic Reach and Achievements
            15.2.2.4    Certifications
        15.2.3    Codex DNA, Inc.
            15.2.3.1    Company Overview
            15.2.3.2    Product Portfolio
            15.2.3.3    Demographic Reach and Achievements
            15.2.3.4    Certifications
        15.2.4    Agilent Technologies, Inc.
            15.2.4.1    Company Overview
            15.2.4.2    Product Portfolio
            15.2.4.3    Demographic Reach and Achievements
            15.2.4.4    Certifications
        15.2.5    TransGen Biotech Co., Ltd. 
            15.2.5.1    Company Overview
            15.2.5.2    Product Portfolio
            15.2.5.3    Demographic Reach and Achievements
            15.2.5.4    Certifications
        15.2.6    Others
16    Key Trends  and Developments in the Market

 

List of Key Figures and Tables

1.    Global Cloning and Mutagenesis Market: Key Industry Highlights, 2018 and 2028
2.    Global Cloning and Mutagenesis Historical Market: Breakup by Product (USD Million), 2018-2022
3.    Global Cloning and Mutagenesis Market Forecast: Breakup by Product (USD Million), 2023-2028
4.    Global Cloning and Mutagenesis Historical Market: Breakup by Technique (USD Million), 2018-2022
5.    Global Cloning and Mutagenesis Market Forecast: Breakup by Technique (USD Million), 2023-2028
6.    Global Cloning and Mutagenesis Historical Market: Breakup by End Use (USD Million), 2018-2022
7.    Global Cloning and Mutagenesis Market Forecast: Breakup by End Use (USD Million), 2023-2028
8.    Global Cloning and Mutagenesis Historical Market: Breakup by Region (USD Million), 2018-2022
9.    Global Cloning and Mutagenesis Market Forecast: Breakup by Region (USD Million), 2023-2028
10.    North America Cloning and Mutagenesis Historical Market: Breakup by Country (USD Million), 2018-2022
11.    North America Cloning and Mutagenesis Market Forecast: Breakup by Country (USD Million), 2023-2028
12.    Europe Cloning and Mutagenesis Historical Market: Breakup by Country (USD Million), 2018-2022
13.    Europe Cloning and Mutagenesis Market Forecast: Breakup by Country (USD Million), 2023-2028
14.    Asia Pacific Cloning and Mutagenesis Historical Market: Breakup by Country (USD Million), 2018-2022
15.    Asia Pacific Cloning and Mutagenesis Market Forecast: Breakup by Country (USD Million), 2023-2028
16.    Latin America Cloning and Mutagenesis Historical Market: Breakup by Country (USD Million), 2018-2022
17.    Latin America Cloning and Mutagenesis Market Forecast: Breakup by Country (USD Million), 2023-2028
18.    Middle East and Africa Cloning and Mutagenesis Historical Market: Breakup by Country (USD Million), 2018-2022
19.    Middle East and Africa Cloning and Mutagenesis Market Forecast: Breakup by Country (USD Million), 2023-2028
20.    Global Cloning and Mutagenesis Market Structure

Key Questions Answered in the Report

The global market is assessed to grow at a CAGR of 17.0% between 2023 and 2028.

The major market drivers are the high per capita healthcare expenditure and increasing investment by government in medical research.

The major regions in the market are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

The key market trends include emerging economies along with surging cases of chronic diseases and the increasing investment in biotechnology.

The common types of products types in the market include cloning kits and mutagenesis kit.

The primary techniques used include topo PCR cloning, blunt end cloning, seamless cloning, and site-directed mutagenesis, among others.

The various end uses in the market include biotechnology companies, and academic and research institute, among others.

The major players in the market are Thermo Fisher Scientific Inc., Takara Bio Inc., Codex DNA, Inc., Agilent Technologies, Inc., and TransGen Biotech Co., Ltd., among others.

Purchase Full Report

Mini Report

$ 2199     $1799
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER